Immune‐Mediated Thrombocytopenia in an Ulcerative Colitis Patient After Initiating Filgotinib Treatment: A Case Report
Moderate-to-severe ulcerative colitis can be effectively treated with JAK-1 inhibition, but platelet counts should be closely monitored, especially in active disease. We confirmed immune-mediated thrombocytopenia (ITP) in one of our patients after the initiation of filgotinib. Whether this was drug-induced is uncertain.
Authors
- M. Löwenberg
- M. J. van der Hoff
- F. El‐Morabit
Institutions
- Amsterdam Neuroscience (NL)
- Amsterdam University Medical Centers (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2025-12-25
- DOI
- https://doi.org/10.1002/ccr3.71574
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amsterdam University Medical Centers